C

Corbus Pharmaceuticals Holdings
D

CRBP

7.55000
USD
0.18
(2.44%)
مغلق
حجم التداول
0
الربح لكل سهم
-6
العائد الربحي
-
P/E
-2
حجم السوق
92,387,591
أصول ذات صلة
ABBV
ABBV
0.060
(0.03%)
182.840 USD
A
ACAD
0.040
(0.19%)
21.580 USD
ALNY
ALNY
-3.21
(-1.11%)
286.14 USD
A
AMRN
0.030
(0.27%)
11.000 USD
GILD
GILD
-0.360
(-0.34%)
106.360 USD
I
INVA
-0.010
(-0.05%)
18.820 USD
NVS
NVS
-0.390
(-0.35%)
112.120 USD
Z
ZYME
-0.030
(-0.26%)
11.450 USD
المزيد
الأخبار المقالات

العنوان: Corbus Pharmaceuticals Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.